1. An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Issue 6 (12th February 2014) Authors: Clunie, G P R; Ginawi, A; O'Conner, P; Bearcroft, P W; Garber, S J; Bhagat, S; Grainger, A; Gaston, J S H Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 6(2014) Page Start: 1273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP13 Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study. (25th January 2019) Authors: Li, K; Yang, F; Hayden, K; Strawn, D; Wadman, E; Bhagat, S; Marano, C; Friedman, J R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P281Extracellular RNA is the novel player in hypoxic Stress induced myocardial injury. (23rd April 2018) Authors: Khan, G; Alam, I; Bhagat, S Journal: Cardiovascular research Issue: Volume 114(2018)Supplement 1 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sarcoid sacroiliitis: successful treatment with infliximab. Issue 2 (12th January 2009) Authors: Agrawal, S; Bhagat, S; Dasgupta, B Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 2(2009) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗